Marie‐Laure Ozoux

Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment

Ger‐Jan C.M. Sanderink, C. Guimart, Marie‐Laure Ozoux et al. · Thrombosis Research · 2002 · 196 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers

Ger‐Jan Sanderink, A. Le Liboux, Navin Jariwala et al. · Clinical Pharmacology & Therapeutics · 2002 · 184 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +13

Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study

Jack L. Martin, Edward T.A. Fry, Ger‐Jan C.M. Sanderink et al. · Catheterization and Cardiovascular Interventions · 2004 · 78 citations

Medicine, Pharmacology, Pharmacotherapy +17

Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy

Philippe Beauverger, Marie‐Laure Ozoux, Guillaume Bégis et al. · Cardiovascular Research · 2019 · 54 citations

Medicine, Cardiology, Pharmacology +17

Pharmacodynamic markers in the early clinical assessment of otamixaban, a direct factor Xa inhibitor

Marie‐Laure Ozoux, Valeria Chu, Kelly Simcox et al. · Thrombosis and Haemostasis · 2005 · 32 citations

Medicine, Pharmacokinetics, Pharmacology +14